Immunization Spotlight

National Infant Immunization Week, set for April 24 – April 28, 2017, is an annual observance to highlight the importance of protecting against vaccine-preventable diseases.

Immunization is one of the most successful and cost-effective health interventions, preventing millions of deaths every year. From infants to seniors, immunization protects against diseases such as diphtheria, measles, pertussis (whooping cough), pneumonia, polio, rotavirus, rubella and tetanus. The benefits of immunization are increasingly being extended to adolescents and adults, providing protection against life-threatening diseases such as influenza, meningitis, and cancers (cervical and liver cancers).

Click on these links to Emerging Infectious Diseases articles and podcasts below and learn more about the latest information on vaccine-preventable diseases.

2024

Early Release Cost-effectiveness Analysis of Japanese Encephalitis Vaccination for Children <15 Years of Age, Bangladesh
An Nguyen et al. Volume 30, Number 12—December 2024 Current Issue Estimating Influenza Illnesses Averted by Year-Round and Seasonal Campaign Vaccination for Young Children, Kenya
Radhika Gharpure et al. Volume 30, Number 11—November 2024 Current Issue Risk for Facial Palsy after COVID-19 Vaccination, South Korea, 2021–2022
Dongwon Yoon et al. Volume 30, Number 11—November 2024 Current Issue SARS-CoV-2 Infection in School Settings, Okinawa Prefecture, Japan, 2021–2022
Yoshihiro Takayama et al. Volume 30, Number 11—November 2024 Current Issue Prevalence of Pertactin-Deficient Bordetella pertussis Isolates, Slovenia
Alex-Mikael Barkoff et al. Volume 30, Number 11—November 2024 Mpox Epidemiology and Vaccine Effectiveness, England, 2023
Hannah Charles et al. Volume 30, Number 10—October 2024 Onward Virus Transmission after Measles Secondary Vaccination Failure
Isaac Tranter et al. Volume 30, Number 9—September 2024 Effects of Rotavirus Vaccination Coverage among Infants on Hospital Admission for Gastroenteritis across All Age Groups, Japan, 2011–2019
Kenji Kishimoto et al. Volume 30, Number 9—September 2024 Detection of Nucleocapsid Antibodies Associated with Primary SARS-CoV-2 Infection in Unvaccinated and Vaccinated Blood Donors
Eduard Grebe et al. Volume 30, Number 8—August 2024 Hepatitis B Virus Reactivation after Switch to Cabotegravir/Rilpivirine in Patient with Low Hepatitis B Surface Antibody
Eisuke Adachi et al. Volume 30, Number 8—August 2024 Vaccine Effectiveness against SARS-CoV-2 among Household Contacts during Omicron BA.2–Dominant Period, Japan
Tsuyoshi Ogata et al. Volume 30, Number 7—July 2024 Strategies to Enhance COVID-19 Vaccine Uptake among Prioritized Groups, Uganda–Lessons Learned and Recommendations for Future Pandemics
Daniel Kiiza et al. Volume 30, Number 7—July 2024 Follow-Up Study of Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine Against All-Type and Serotype-Specific Invasive Pneumococcal Disease, Denmark
Katrine Finderup Nielsen et al. Volume 30, Number 6—June 2024 Evaluating Humoral Immunity Elicited by XBB.1.5 Monovalent COVID-19 Vaccine
Xammy Huu Nguyenla et al. Volume 30, Number 6—June 2024 Infection- and Vaccine-Induced SARS-CoV-2 Seroprevalence, Japan, 2023
Ryo Kinoshita et al. Volume 30, Number 6—June 2024 Estimates of SARS-CoV-2 Hospitalization and Fatality Rates in the Prevaccination Period, United States
Isabel Griffin et al. Volume 30, Number 6—June 2024 Trends in Nationally Notifiable Infectious Diseases in Humans and Animals during COVID-19 Pandemic, South Korea
Taehee Chang et al. Volume 30, Number 6—June 2024 Crimean-Congo Hemorrhagic Fever Virus for Clinicians—Epidemiology, Clinical Manifestations, and Prevention
Maria G. Frank et al. Volume 30, Number 5—May 2024 Interventional Study of Nonpharmaceutical Measures to Prevent COVID-19 Aboard Cruise Ships
Varvara A. Mouchtouri et al. Volume 30, Number 5—May 2024 Crimean-Congo Hemorrhagic Fever Virus for Clinicians—Diagnosis, Clinical Management, and Therapeutics
Maria G. Frank et al. Volume 30, Number 5—May 2024 Protective Efficacy of Lyophilized Vesicular Stomatitis Virus–Based Vaccines in Animal Model
Abd’jeleel Salawudeen et al. Volume 30, Number 5—May 2024 Mpox Diagnosis, Behavioral Risk Modification, and Vaccination Uptake among Gay, Bisexual, and Other Men Who Have Sex with Men, United Kingdom, 2022
Dana Ogaz et al. Volume 30, Number 5—May 2024 COVID-19 Vaccination Site Accessibility, United States, December 11, 2020–March 29, 2022
Randy Yee et al. Volume 30, Number 5—May 2024 Podcast Crimean Congo Hemorrhagic Fever Virus for Clinicians—Virology, Pathogenesis, and Pathology
Maria G. Frank et al. Volume 30, Number 5—May 2024 presentation_01

Listen to the podcast SARS-CoV-2 IgG Levels as Predictors of XBB Variant Neutralization, Israel, 2022 and 2023
Yaniv Lustig et al. Volume 30, Number 5—May 2024 Analysis of Suspected Measles Cases with Discrepant Measles-Specific IgM and rRT-PCR Test Results, Japan
Yumani Kuba et al. Volume 30, Number 5—May 2024 Effects of Shock and Vibration on Product Quality during Last-Mile Transportation of Ebola Vaccine under Refrigerated Conditions
Linda Bus-Jacobs et al. Volume 30, Number 4—April 2024 Novel Oral Poliovirus Vaccine 2 Safety Evaluation during Nationwide Supplemental Immunization Activity, Uganda, 2022
Farrell A. Tobolowsky et al. Volume 30, Number 4—April 2024 Breaking Through: My Life in Science
Sara C. Keller Volume 30, Number 4—April 2024 Melioidosis in Patients with COVID-19 Exposed to Contaminated Tap Water, Thailand, 2021
Panupong Tantirat et al. Volume 30, Number 4—April 2024 RISE-Vac—Co-Production of Vaccine Education Materials with Persons Living in Prison
Femi Laryea-Adekimi et al. Volume 30, Supplement—March 2024 Effect of Pneumococcal Conjugate Vaccine on Pneumonia Incidence Rates among Children 2–59 Months of Age, Mongolia, 2015–2021
Claire von Mollendorf et al. Volume 30, Number 3—March 2024 Population-Based Evaluation of Vaccine Effectiveness against SARS-CoV-2 Infection, Severe Illness, and Death, Taiwan
Cheng-Yi Lee et al. Volume 30, Number 3—March 2024 Key Challenges for Respiratory Virus Surveillance while Transitioning out of Acute Phase of COVID-19 Pandemic
Oliver Eales et al. Volume 30, Number 2—February 2024 Residual Immunity from Smallpox Vaccination and Possible Protection from Mpox, China
Yu Huang et al. Volume 30, Number 2—February 2024 SARS-CoV-2 Infection in Beaver Farm, Mongolia, 2021
Taichiro Takemura et al. Volume 30, Number 2—February 2024 Impact of Meningococcal ACWY Vaccination Program during 2017–18 Epidemic, Western Australia, Australia
Krist Ewe et al. Volume 30, Number 2—February 2024 COVID-19–Related School Closures, United States, July 27, 2020–June 30, 2022
Nicole Zviedrite et al. Volume 30, Number 1—January 2024 Molecular Evolution and Increasing Macrolide Resistance of Bordetella pertussis, Shanghai, China, 2016–2022
Pan Fu et al. Volume 30, Number 1—January 2024 Population-Based Study of Pertussis Incidence and Risk Factors among Persons >50 Years of Age, Australia
Rodney Pearce et al. Volume 30, Number 1—January 2024

2023

Substantial Diversity in Cocirculating Omicron Lineages in Hospital Setting, Porto Alegre, Brazil
Tiago F. Andreis et al. Volume 29, Number 12—December 2023 Cost of Acute and Sequelae Care for Japanese Encephalitis Patients, Bangladesh, 2011–2021
Rebeca Sultana et al. Volume 29, Number 12—December 2023 Estimate of COVID-19 Deaths, China, December 2022–February 2023
Zhanwei Du et al. Volume 29, Number 10—October 2023 Characteristics of and Deaths among 333 Persons with Tuberculosis and COVID-19 in Cross-Sectional Sample from 25 Jurisdictions, United States
Scott A. Nabity et al. Volume 29, Number 10—October 2023 Participatory Mathematical Modeling Approach for Policymaking during the First Year of the COVID-19 Crisis, Jordan
Saverio Bellizzi et al. Volume 29, Number 9—September 2023 Interspecies Transmission of Swine Influenza A Viruses and Human Seasonal Vaccine-Mediated Protection Investigated in Ferret Model
Pauline M. van Diemen et al. Volume 29, Number 9—September 2023 Seroprevalence of Vibrio cholerae in Adults, Haiti, 2017
Wilfredo R. Matias et al. Volume 29, Number 9—September 2023 Evaluating SARS-CoV-2 Saliva and Dried Blood Spot Surveillance Strategies in a Congregate Population
Liana R. Andronescu et al. Volume 29, Number 9—September 2023 Novel Avian Influenza Virus (H5N1) Clade 2.3.4.4b Reassortants in Migratory Birds, China
Jing Yang et al. Volume 29, Number 6—June 2023 High Prevalence of SARS-CoV-2 Omicron Infection Despite High Seroprevalence, Sweden, 2022
Ramona Groenheit et al. Volume 29, Number 6—June 2023 Probable Transmission of SARS-CoV-2 from African Lion to Zoo Employees, Indiana, USA, 2021
Audrey A. Siegrist et al. Volume 29, Number 6—June 2023 SARS-CoV-2 Vaccine Effectiveness against Omicron Variant in Infection-Naive Population, Australia, 2022
Lauren E. Bloomfield et al. Volume 29, Number 6—June 2023 Enhanced Adenovirus Vaccine Safety Surveillance in Military Setting, United States
John Iskander et al. Volume 29, Number 6—June 2023 Disparities in Implementing COVID-19 Prevention Strategies in Public Schools, United States, 2021–22 School Year
Sanjana Pampati et al. Volume 29, Number 5—May 2023 A Deadly Kiss
Byron Breedlove Volume 29, Number 5—May 2023 Two-Year Cohort Study of SARS-CoV-2, Verona, Italy, 2020‒2022
Zeno Bisoffi et al. Volume 29, Number 4—April 2023 Monitoring Temporal Changes in SARS-CoV-2 Spike Antibody Levels and Variant-Specific Risk for Infection, Dominican Republic, March 2021–August 2022
Eric J. Nilles et al. Volume 29, Number 4—April 2023 Effectiveness of BNT162b2 Vaccine against Omicron Variant Infection among Children 5–11 Years of Age, Israel
Aharona Glatman-Freedman et al. Volume 29, Number 4—April 2023 Emergence and Persistent Dominance of SARS-CoV-2 Omicron BA.2.3.7 Variant, Taiwan
Pei-Lan Shao et al. Volume 29, Number 4—April 2023 Risk Factors for Reinfection with SARS-CoV-2 Omicron Variant among Previously Infected Frontline Workers
Katherine D. Ellingson et al. Volume 29, Number 3—March 2023 Increase in Colorado Tick Fever Virus Disease Cases and Effect of COVID-19 Pandemic on Behaviors and Testing Practices, Montana, 2020
Raymond A. Soto et al. Volume 29, Number 3—March 2023 Comparative Effectiveness of COVID-19 Vaccines in Preventing Infections and Disease Progression from SARS-CoV-2 Omicron BA.5 and BA.2, Portugal
Irina Kislaya et al. Volume 29, Number 3—March 2023 Yellow Fever Vaccine–Associated Viscerotropic Disease among Siblings, São Paulo State, Brazil
Eder Gatti Fernandes et al. Volume 29, Number 3—March 2023 Possible Mpox Protection from Smallpox Vaccine–Generated Antibodies among Older Adults
Iván Sanz-Muñoz et al. Volume 29, Number 3—March 2023 Age-Stratified Model to Assess Health Outcomes of COVID-19 Vaccination Strategies, Ghana
Sylvia K. Ofori et al. Volume 29, Number 2—February 2023 Hepatitis E Virus Outbreak among Tigray War Refugees from Ethopia, Sudan
Andrew S. Azman et al. Volume 29, Number 2—February 2023 Correlates of Protection, Thresholds of Protection, and Immunobridging among Persons with SARS-CoV-2 Infection
David S. Khoury et al. Volume 29, Number 2—February 2023 Hepatitis E Virus Outbreak among Tigray War Refugees from Ethiopia, Sudan (Response)
Ayman Ahmed et al. Volume 29, Number 2—February 2023 Monkeypox Virus Infection in 18-Year-Old Woman after Sexual Intercourse, France, September 2022
Alexandre Vallée et al. Volume 29, Number 1—January 2023 Seroepidemiology and Carriage of Diphtheria in Epidemic-Prone Area and Implications for Vaccination Policy, Vietnam
Noriko Kitamura et al. Volume 29, Number 1—January 2023 High SARS-CoV-2 Seroprevalence after Second COVID-19 Wave (October 2020–April 2021), Democratic Republic of the Congo
Yannick Munyeku-Bazitama et al. Volume 29, Number 1—January 2023

2022

The Future of Infodemic Surveillance as Public Health Surveillance
Howard Chiou et al. Volume 28, Supplement—December 2022 Past as Prologue—Use of Rubella Vaccination Program Lessons to Inform COVID-19 Vaccination
Meredith G. Dixon et al. Volume 28, Supplement—December 2022 Effects of COVID-19 on Vaccine-Preventable Disease Surveillance Systems in the World Health Organization African Region, 2020
John Paul Bigouette et al. Volume 28, Supplement—December 2022 Effectiveness of Whole-Virus COVID-19 Vaccine among Healthcare Personnel, Lima, Peru
Carmen S. Arriola et al. Volume 28, Supplement—December 2022 Determining Gaps in Publicly Shared SARS-CoV-2 Genomic Surveillance Data by Analysis of Global Submissions
Elizabeth C. Ohlsen et al. Volume 28, Supplement—December 2022 CDC’s COVID-19 International Vaccine Implementation and Evaluation Program and Lessons from Earlier Vaccine Introductions
Heidi M. Soeters et al. Volume 28, Supplement—December 2022 Leveraging International Influenza Surveillance Systems and Programs during the COVID-19 Pandemic
Perrine Marcenac et al. Volume 28, Supplement—December 2022 Effects of Decreased Immunization Coverage for Hepatitis B Virus Caused by COVID-19 in World Health Organization Western Pacific and African Regions, 2020
Hyacinte J. Kabore et al. Volume 28, Supplement—December 2022 Use of Epidemiology Surge Support to Enhance Robustness and Expand Capacity of SARS-CoV-2 Pandemic Response, South Africa
Rayna Taback-Esra et al. Volume 28, Supplement—December 2022 Leveraging HIV Program and Civil Society to Accelerate COVID-19 Vaccine Uptake, Zambia
Patricia Bobo et al. Volume 28, Supplement—December 2022 Leveraging Lessons Learned from Yellow Fever and Polio Immunization Campaigns during COVID-19 Pandemic, Ghana, 2021
Kwame Amponsa-Achiano et al. Volume 28, Supplement—December 2022 Partnerships, Collaborations, and Investments Integral to CDC’s International Response to COVID-19
Rochelle P. Walensky Volume 28, Supplement—December 2022 A Nationally Representative Survey of COVID-19 in Pakistan, 2021–2022
Sarah Aheron et al. Volume 28, Supplement—December 2022 Podcast Contribution of PEPFAR-Supported HIV and TB Molecular Diagnostic Networks to COVID-19 Testing Preparedness in 16 Countries
Erin Rottinghaus Romano et al. Volume 28, Supplement—December 2022 presentation_01

Listen to the podcast Omicron BA.5 Neutralization among Vaccine-Boosted Persons with Prior Omicron BA.1/BA.2 Infections
Rune M. Pedersen et al. Volume 28, Number 12—December 2022 Probable Aerosol Transmission of SARS-CoV-2 through Floors and Walls of Quarantine Hotel, Taiwan, 2021
Hsin-Yi Wei et al. Volume 28, Number 12—December 2022 Myocarditis Attributable to Monkeypox Virus Infection in 2 Patients, United States, 2022
Guillermo Rodriguez-Nava et al. Volume 28, Number 12—December 2022 Socioeconomic Inequalities in COVID-19 Vaccination and Infection in Adults, Catalonia, Spain
Elena Roel et al. Volume 28, Number 11—November 2022 Vaccine Effectiveness against SARS-CoV-2 Variant P.1 in Nursing-Facility Residents, Washington, USA, April 2021
James W. Lewis et al. Volume 28, Number 11—November 2022 Monkeypox in Patient Immunized with ACAM2000 Smallpox Vaccine During 2022 Outbreak
Matthew Turner et al. Volume 28, Number 11—November 2022 Effectiveness of Second mRNA COVID-19 Booster Vaccine in Immunocompromised Persons and Long-Term Care Facility Residents
Yoo-Yeon Kim et al. Volume 28, Number 11—November 2022 Age-Stratified Seroprevalence of SARS-CoV-2 Antibodies before and during the Vaccination Era, Japan, February 2020–March 2022
Seiya Yamayoshi et al. Volume 28, Number 11—November 2022 Effect of COVID-19 Pandemic on Invasive Pneumococcal Disease in Children, Catalonia, Spain
Pilar Ciruela et al. Volume 28, Number 11—November 2022 Spatiotemporal Patterns of Anthrax, Vietnam, 1990–2015
Morgan A. Walker et al. Volume 28, Number 11—November 2022 SARS-CoV-2 Omicron BA.1 Challenge after Ancestral or Delta Infection in Mice
Mariana Baz et al. Volume 28, Number 11—November 2022 Importation and Circulation of Vaccine-Derived Poliovirus Serotype 2, Senegal, 2020–2021
Martin Faye et al. Volume 28, Number 10—October 2022 SARS-CoV-2 Secondary Attack Rates in Vaccinated and Unvaccinated Household Contacts during Replacement of Delta with Omicron Variant, Spain
Israel López-Muñoz et al. Volume 28, Number 10—October 2022 Three-Dose Primary Series of Inactivated COVID-19 Vaccine for Persons Living with HIV, Hong Kong
Denise Pui Chung Chan et al. Volume 28, Number 10—October 2022 SARS-CoV-2 Vaccine Breakthrough by Omicron and Delta Variants, New York, USA
Alexander C. Keyel et al. Volume 28, Number 10—October 2022 Transmission Dynamics and Effectiveness of Control Measures during COVID-19 Surge, Taiwan, April–August 2021
Andrei R. Akhmetzhanov et al. Volume 28, Number 10—October 2022 Infection Rate of SARS-CoV-2 in Asymptomatic Healthcare Workers, Sweden, June 2022
Kim Blom et al. Volume 28, Number 10—October 2022 Effectiveness of Booster and Influenza Vaccines against COVID-19 among Healthcare Workers, Taiwan
Jun Yi Sim et al. Volume 28, Number 10—October 2022 Podcast Shortening Duration of Swine Exhibitions to Reduce Risk for Zoonotic Transmission of Influenza A Virus
Dillon S. McBride et al. Volume 28, Number 10—October 2022 presentation_01

Listen to the podcast Social and Behavioral Factors Associated with Lack of Intent to Receive COVID-19 Vaccine, Japan
Takeshi Arashiro et al. Volume 28, Number 9—September 2022 Epidemiology of Infections with SARS-CoV-2 Omicron BA.2 Variant, Hong Kong, January–March 2022
Yonatan M. Mefsin et al. Volume 28, Number 9—September 2022 Evaluation of Effectiveness of Global COVID-19 Vaccination Campaign
Daihai He et al. Volume 28, Number 9—September 2022 Infection with SARS-CoV-2 Omicron Variant 24 Days after Non-Omicron Infection, Pennsylvania, USA
Arlene G. Seid et al. Volume 28, Number 9—September 2022 Age-Dependent Effects of COVID-19 Vaccine and of Healthcare Burden on COVID-19 Deaths, Tokyo, Japan
Yura K. Ko et al. Volume 28, Number 9—September 2022 Podcast Pathogenesis and Transmissibility of North American Highly Pathogenic Avian Influenza A(H5N1) Virus in Ferrets
Joanna A. Pulit-Penaloza et al. Volume 28, Number 9—September 2022 presentation_01

Listen to the podcast Effectiveness of Naturally Acquired and Vaccine-Induced Immune Responses to SARS-CoV-2 Mu Variant
Edmilson F. de Oliveira-Filho et al. Volume 28, Number 8—August 2022 Characterization of Emerging Serotype 19A Pneumococcal Strains in Invasive Disease and Carriage, Belgium
Stefanie Desmet et al. Volume 28, Number 8—August 2022 Estimating COVID-19 Vaccine Effectiveness for Skilled Nursing Facility Healthcare Personnel, California, USA
Monise Magro et al. Volume 28, Number 8—August 2022 Serial Intervals for SARS-CoV-2 Omicron and Delta Variants, Belgium, November 19–December 31, 2021
Cécile Kremer et al. Volume 28, Number 8—August 2022 Factors Associated with Delayed or Missed Second-Dose mRNA COVID-19 Vaccination among Persons >12 Years of Age, United States
Lu Meng et al. Volume 28, Number 8—August 2022 Podcast Increased Incidence of Invasive Pneumococcal Disease among Children after COVID-19 Pandemic, England
Marta Bertran et al. Volume 28, Number 8—August 2022 presentation_01

2021

Limited and Short-Lasting Virus Neutralizing Titers Induced by Inactivated SARS-CoV-2 Vaccine
Taweewun Hunsawong et al. Volume 27, Number 12—December 2021 Incidence Trends for SARS-CoV-2 Alpha and Beta Variants, Finland, Spring 2021
Ravi Kant et al. Volume 27, Number 12—December 2021 Guillain-Barré Syndrome Associated with COVID-19 Vaccination
Shih-Chieh Shao et al. Volume 27, Number 12—December 2021 Fatal Systemic Capillary Leak Syndrome after SARS-CoV-2 Vaccination in Patient with Multiple Myeloma
Gwang-Jun Choi et al. Volume 27, Number 11—November 2021 Fatal Multisystem Inflammatory Syndrome in Adult after SARS-CoV-2 Natural Infection and COVID-19 Vaccination
Heather N. Grome et al. Volume 27, Number 11—November 2021 Yet Another Potential Age-Old Nonpharmaceutical Intervention
Kathleen Gensheimer et al. Volume 27, Number 11—November 2021 Effectiveness of BNT162b2 Vaccine in Adolescents during Outbreak of SARS-CoV-2 Delta Variant Infection, Israel, 2021
Aharona Glatman-Freedman et al. Volume 27, Number 11—November 2021 Breakthrough Infections of SARS-CoV-2 Gamma Variant in Fully Vaccinated Gold Miners, French Guiana, 2021
Nicolas Vignier et al. Volume 27, Number 10—October 2021 Direct and Indirect Effectiveness of mRNA Vaccination against Severe Acute Respiratory Syndrome Coronavirus 2 in Long-Term Care Facilities, Spain
Susana Monge et al. Volume 27, Number 10—October 2021 Burden of Influenza-Associated Respiratory Hospitalizations, Vietnam, 2014–2016
Nguyen Cong Khanh et al. Volume 27, Number 10—October 2021 Invasive Meningococcal Disease, 2011–2020, and Impact of the COVID-19 Pandemic, England
Sathyavani Subbarao et al. Volume 27, Number 9—September 2021 Perinatal Outcomes of Asynchronous Influenza Vaccination, Ceará, Brazil, 2013–2018
José Q. Filho et al. Volume 27, Number 9—September 2021 Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children
Corinne Levy et al. Volume 27, Number 8—August 2021 Outbreak of SARS-CoV-2 B.1.1.7 Lineage after Vaccination in Long-Term Care Facility, Germany, February–March 2021
Pinkus Tober-Lau et al. Volume 27, Number 8—August 2021 Considerations for Establishing Successful Coronavirus Disease Vaccination Programs in Africa
Victor Williams et al. Volume 27, Number 8—August 2021 Whole-Genome Sequencing of SARS-CoV-2 from Quarantine Hotel Outbreak
Lex E.X. Leong et al. Volume 27, Number 8—August 2021 Epidemiology of COVID-19 in Prisons, England, 2020
Wendy M. Rice et al. Volume 27, Number 8—August 2021 Delayed Antibody and T-Cell Response to BNT162b2 Vaccination in the Elderly, Germany
Tatjana Schwarz et al. Volume 27, Number 8—August 2021 Modeling Immune Evasion and Vaccine Limitations by Targeted Nasopharyngeal Bordetella pertussis Inoculation in Mice
Illiassou Hamidou Soumana et al. Volume 27, Number 8—August 2021 Whole-Genome Analysis of Streptococcus pneumoniae Serotype 4 Causing Outbreak of Invasive Pneumococcal Disease, Alberta, Canada
James D. Kellner et al. Volume 27, Number 7—July 2021 Assessing Community Vulnerability over 3 Waves of COVID-19 Pandemic, Hong Kong, China
Qiuyan Liao et al. Volume 27, Number 7—July 2021 Effects of COVID-19 Vaccination Timing and Risk Prioritization on Mortality Rates, United States
Xutong Wang et al. Volume 27, Number 7—July 2021 Psychobehavioral Responses and Likelihood of Receiving COVID-19 Vaccines during the Pandemic, Hong Kong
Kin On Kwok et al. Volume 27, Number 7—July 2021 Multisystem Inflammatory Syndrome after SARS-CoV-2 Infection and COVID-19 Vaccination
Mark B. Salzman et al. Volume 27, Number 7—July 2021 Highly Pathogenic Avian Influenza A(H5N8) Virus in Swans, China, 2020
Xiang Li et al. Volume 27, Number 6—June 2021 Postvaccination COVID-19 among Healthcare Workers, Israel
Zohaib Yousaf et al. Volume 27, Number 6—June 2021 Pertactin-Deficient Bordetella pertussis, Vaccine-Driven Evolution, and Reemergence of Pertussis
Longhuan Ma et al. Volume 27, Number 6—June 2021 Twenty-Year Public Health Impact of 7- and 13-Valent Pneumococcal Conjugate Vaccines in US Children
Matt Wasserman et al. Volume 27, Number 6—June 2021 Serotype-Switch Variant of Multidrug-Resistant Streptococcus pneumoniae Sequence Type 271
Erin M. Scherer et al. Volume 27, Number 6—June 2021 Neurologic Disease after Yellow Fever Vaccination, São Paulo, Brazil, 2017–2018
Ana Freitas Ribeiro et al. Volume 27, Number 6—June 2021 Coordinated Response to Imported Vaccine-Derived Poliovirus Infection, Barcelona, Spain, 2019–2020
Dolores Álamo-Junquera et al. Volume 27, Number 5—May 2021 Podcast Global Trends in Norovirus Genotype Distribution among Children with Acute Gastroenteritis
Jennifer L. Cannon et al. Volume 27, Number 5—May 2021 presentation_01

Listen to the podcast Postvaccination COVID-19 among Healthcare Workers, Israel
Sharon Amit et al. Volume 27, Number 4—April 2021 Addressing Reemergence of Diphtheria among Adolescents through Program Integration in India
Kiran Kumar Maramraj et al. Volume 27, Number 3—March 2021 Podcast Isolate-Based Surveillance of Bordetella pertussis, Austria, 2018–2020
Adriana Cabal et al. Volume 27, Number 3—March 2021 presentation_01

Listen to the podcast Vaccine-Derived Polioviruses, Central African Republic, 2019
Marie-Line Joffret et al. Volume 27, Number 2—February 2021 Hospitalization for Invasive Pneumococcal Diseases in Young Children before Use of 13-Valent Pneumococcal Conjugate Vaccine, Suzhou, China
Kaile Chen et al. Volume 27, Number 1—January 2021 Etiology of Severe Acute Respiratory Infections, Bangladesh, 2017
Md R. Rahaman et al. Volume 27, Number 1—January 2021 Impact of Human Papillomavirus Vaccination, Rwanda and Bhutan
Iacopo Baussano et al. Volume 27, Number 1—January 2021 Post–13-Valent Pneumococcal Conjugate Vaccine Dynamics in Young Children of Serotypes Included in Candidate Extended-Spectrum Conjugate Vaccines
Shalom Ben-Shimol et al. Volume 27, Number 1—January 2021

2020

Control and Prevention of Anthrax, Texas, USA, 2019
Tom Sidwa et al. Volume 26, Number 12—December 2020 Podcast Role of Oral Rabies Vaccines in the Elimination of Dog-Mediated Human Rabies Deaths
Ryan M. Wallace et al. Volume 26, Number 12—December 2020 presentation_01

Listen to the podcast Streptococcus pneumoniae Serotype 12F-CC4846 and Invasive Pneumococcal Disease after Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Japan, 2015–2017
Satoshi Nakano et al. Volume 26, Number 11—November 2020 Measuring Timeliness of Outbreak Response in the World Health Organization African Region, 2017–2019
Benido Impouma et al. Volume 26, Number 11—November 2020 Thresholds versus Anomaly Detection for Surveillance of Pneumonia and Influenza Mortality
Timothy L. Wiemken et al. Volume 26, Number 11—November 2020 Podcast Nowcasting (Short-Term Forecasting) of Influenza Epidemics in Local Settings, Sweden, 2008–2019
Armin Spreco et al. Volume 26, Number 11—November 2020 presentation_01

Listen to the podcast Challenges to Achieving Measles Elimination, Georgia, 2013–2018
Nino Khetsuriani et al. Volume 26, Number 11—November 2020 Effectiveness of 23-Valent Pneumococcal Polysaccharide Vaccine against Invasive Pneumococcal Disease in Adults, Japan, 2013–2017
Reiko Shimbashi et al. Volume 26, Number 10—October 2020 Incidence and Seroprevalence of Avian Influenza in a Cohort of Backyard Poultry Growers, Egypt, August 2015–March 2019
Mokhtar R. Gomaa et al. Volume 26, Number 9—September 2020 Analysis of MarketScan Data for Immunosuppressive Conditions and Hospitalizations for Acute Respiratory Illness, United States
Manish Patel et al. Volume 26, Number 8—August 2020 Case Manifestations and Public Health Response for Outbreak of Meningococcal W Disease, Central Australia, 2017
Eva L. Sudbury et al. Volume 26, Number 7—July 2020 Meningococcal W135 Disease Vaccination Intent, the Netherlands, 2018–2019
Marion de Vries et al. Volume 26, Number 7—July 2020 Failures of 13-Valent Conjugated Pneumococcal Vaccine in Age-Appropriately Vaccinated Children 2–59 Months of Age, Spain
Sergi Hernández et al. Volume 26, Number 6—June 2020 Statin Use and Influenza Vaccine Effectiveness in Persons ≥ 65 Years of Age, Taiwan
Lung-Wen Tsai et al. Volume 26, Number 6—June 2020 Hepatitis A Hospitalization Costs, United States, 2017
Megan G. Hofmeister et al. Volume 26, Number 5—May 2020 Workshop Report on Global Harmonization of Enterovirus Vaccines
Tzu-Yu Weng et al. Volume 26, Number 4—April 2020 Podcast Pregnancy Outcomes among Women Receiving rVSVΔ-ZEBOV-GP Ebola Vaccine during the Sierra Leone Trial to Introduce a Vaccine against Ebola
Jennifer K. Legardy-Williams et al. Volume 26, Number 3—March 2020 presentation_01

Listen to the podcast Randomized Trial of 2 Schedules of Meningococcal B Vaccine in Adolescents and Young Adults, Canada
Joanne M. Langley et al. Volume 26, Number 3—March 2020 Chlamydia abortus in Pregnant Woman with Acute Respiratory Distress Syndrome
Nicolas Pichon et al. Volume 26, Number 3—March 2020 Progressive Vaccinia Acquired through Zoonotic Transmission in a Patient with HIV/AIDS, Colombia
Katherine Laiton-Donato et al. Volume 26, Number 3—March 2020 Mycobacterium tuberculosis Beijing Lineage and Risk for Tuberculosis in Child Household Contacts, Peru
Chuan-Chin Huang et al. Volume 26, Number 3—March 2020 Need for BCG Vaccination to Prevent TB in High-Incidence Countries and Populations
Shalini Pooransingh et al. Volume 26, Number 3—March 2020 Varicella in Adult Foreigners at a Referral Hospital, Central Tokyo, Japan, 2012–2016
Saho Takaya et al. Volume 26, Number 1—January 2020 Effect of Pediatric Influenza Vaccination on Antibiotic Resistance, England and Wales
Chungman Chae et al. Volume 26, Number 1—January 2020 Plans for Nationwide Serosurveillance Network in Vietnam
Dang Duc Anh et al. Volume 26, Number 1—January 2020 Data Behind Vaccine Hesitancy and Latest Updates on Vaccines in the Pipeline—2019 Annual Conference on Vaccinology Research, April 3–5, 2019
William Schaffner et al. Volume 26, Number 1—January 2020 Vaccine Effectiveness against DS-1–Like Rotavirus Strains
Toyoko Nakagomi Volume 26, Number 1—January 2020

2019

Recombination between Vaccine and Field Strains of Porcine Reproductive and Respiratory Syndrome Virus
Anping Wang et al. Volume 25, Number 12—December 2019 Rare Detection of Bordetella pertussis Pertactin-Deficient Strains in Argentina
Francisco Carriquiriborde et al. Volume 25, Number 11—November 2019 Vaccine-Derived Poliovirus Infection among Patients with Primary Immunodeficiency and Effect of Patient Screening on Disease Outcomes, Iran
Mohammadreza Shaghaghi et al. Volume 25, Number 11—November 2019 Nasopharyngeal Pneumococcal Density during Asymptomatic Respiratory Virus Infection and Risk for Subsequent Acute Respiratory Illness
Leigh M. Howard et al. Volume 25, Number 11—November 2019 Geospatial Variation in Rotavirus Vaccination in Infants, United States, 2010–2017
Mary A.M. Rogers et al. Volume 25, Number 10—October 2019 Case Studies and Literature Review of Pneumococcal Septic Arthritis in Adults
Amandine Dernoncourt et al. Volume 25, Number 10—October 2019 Podcast Effect of Pneumococcal Conjugate Vaccines on Pneumococcal Meningitis, England and Wales, July 1, 2000–June 30, 2016
Godwin Oligbu et al. Volume 25, Number 9—September 2019 presentation_01

Listen to the podcast Vaccine Effectiveness against DS-1–Like Rotavirus Strains in Infants with Acute Gastroenteritis, Malawi, 2013–2015
Khuzwayo C. Jere et al. Volume 25, Number 9—September 2019 Evaluating Temperature Sensitivity of Vesicular Stomatitis Virus–Based Vaccines
Derek R. Stein et al. Volume 25, Number 8—August 2019 Etymologia: Poliomyelitis
Ronnie Henry Volume 25, Number 8—August 2019 17DD Yellow Fever Revaccination and Heightened Long-Term Immunity in Populations of Disease-Endemic Areas, Brazil
Ana Carolina Campi-Azevedo et al. Volume 25, Number 8—August 2019 Podcast Facility-Associated Release of Polioviruses into Communities—Risks for the Posteradication Era
Ananda S. Bandyopadhyay et al. Volume 25, Number 7—July 2019 presentation_01

Listen to the podcast Pertactin-Negative and Filamentous Hemagglutinin-Negative Bordetella pertussis, Australia, 2013–2017
Zheng Xu et al. Volume 25, Number 6—June 2019 Podcast Use of Single-Injection Recombinant Vesicular Stomatitis Virus Vaccine to Protect Nonhuman Primates Against Lethal Nipah Virus Disease
Chad E. Mire et al. Volume 25, Number 6—June 2019 presentation_01

Listen to the podcast Outbreak of Vaccinia Virus Infection from Occupational Exposure, China, 2017
Bing Lu et al. Volume 25, Number 6—June 2019 Rabies Acquired through Mucosal Exposure, China, 2013
Hong Zhao et al. Volume 25, Number 5—May 2019 Staphylococcus aureus Bacteremia in Children of Rural Areas of The Gambia, 2008–2015
Aderonke Odutola et al. Volume 25, Number 4—April 2019 Resurgence of Vaccine-Preventable Diseases in Venezuela as a Regional Public Health Threat in the Americas
Alberto E. Paniz-Mondolfi et al. Volume 25, Number 4—April 2019 Human-Origin Influenza A(H3N2) Reassortant Viruses in Swine, Southeast Mexico
Martha I. Nelson et al. Volume 25, Number 4—April 2019 Genomic Survey of Bordetella pertussis Diversity, United States, 2000–2013
Michael R. Weigand et al. Volume 25, Number 4—April 2019 The Task Force for Child Survival: Secrets of Successful Coalitions
Jane M. Gould Volume 25, Number 4—April 2019 Prior Vaccination and Effectiveness of Communication Strategies Used to Describe Infectious Diseases
Thomas S. Valley et al. Volume 25, Number 4—April 2019 Podcast University-Based Outbreaks of Meningococcal Disease Caused by Serogroup B, United States, 2013–2018
Heidi M. Soeters et al. Volume 25, Number 3—March 2019 presentation_01

Listen to the podcast Podcast International Biological Reference Preparations for Epidemic Infectious Diseases
Tommy Rampling et al. Volume 25, Number 2—February 2019 presentation_01

Listen to the podcast Public Health–Driven Research and Innovation for Next-Generation Influenza Vaccines, European Union
Adoración Navarro-Torné et al. Volume 25, Number 2—February 2019 Influenza H5/H7 Virus Vaccination in Poultry and Reduction of Zoonotic Infections, Guangdong Province, China, 2017–18
Jie Wu et al. Volume 25, Number 1—January 2019 Podcast In Memoriam: Katrin Susanne Kohl (1964–2018)
Nina Marano et al. Volume 25, Number 1—January 2019 presentation_01

Listen to the podcast

2018

Effects of Pneumococcal Conjugate Vaccine on Genotypic Penicillin Resistance and Serotype Changes, Japan, 2010–2017
Kimiko Ubukata et al. Volume 24, Number 11—November 2018 Fatal Case of Diphtheria and Risk for Reemergence, Singapore
Yingqi Lai et al. Volume 24, Number 11—November 2018 Adenovirus-Associated Influenza-Like Illness among College Students, Pennsylvania, USA
Holly M. Biggs et al. Volume 24, Number 11—November 2018 Effect of Inactivated Poliovirus Vaccine Campaigns, Pakistan, 2014–2017
Nicholas C. Grassly et al. Volume 24, Number 11—November 2018 Frequent Genetic Mismatch between Vaccine Strains and Circulating Seasonal Influenza Viruses, Hong Kong, China, 1996–2012
Martin C.W. Chan et al. Volume 24, Number 10—October 2018 Effectiveness of Whole, Inactivated, Low Pathogenicity Influenza A(H7N9) Vaccine against Antigenically Distinct, Highly Pathogenic H7N9 Virus
Masato Hatta et al. Volume 24, Number 10—October 2018 Podcast Invasive Pneumococcal Disease in Refugee Children, Germany
Stephanie Perniciaro et al. Volume 24, Number 10—October 2018 presentation_01

Listen to the podcast Revisiting Influenza Vaccination Exemption
Margaret Ryan et al. Volume 24, Number 10—October 2018 Rapid Spread of Pneumococcal Nonvaccine Serotype 7C Previously Associated with Vaccine Serotype 19F, England and Wales
Ashley Makwana et al. Volume 24, Number 10—October 2018 Outbreak of Pneumococcal Meningitis, Paoua Subprefecture, Central African Republic, 2016–2017
Matthew E. Coldiron et al. Volume 24, Number 9—September 2018 Fatal Nongroupable Neisseria meningitidis Disease in Vaccinated Patient Receiving Eculizumab
Deirdre Nolfi-Donegan et al. Volume 24, Number 8—August 2018 Pediatric Complicated Pneumonia Caused by Streptococcus pneumoniae Serotype 3 in 13-Valent Pneumococcal Conjugate Vaccinees, Portugal, 2010–2015
Catarina Silva-Costa et al. Volume 24, Number 7—July 2018 Pneumococcal Meningitis in Adults after Introduction of PCV7 and PCV13, Israel, July 2009–June 2015
Gili Regev-Yochay et al. Volume 24, Number 7—July 2018 Progress in Vaccine-Preventable and Respiratory Infectious Diseases—First 10 Years of the CDC National Center for Immunization and Respiratory Diseases, 2006–2015
Anne Schuchat et al. Volume 24, Number 7—July 2018 Mapping of the US Domestic Influenza Virologic Surveillance Landscape
Barbara Jester et al. Volume 24, Number 7—July 2018 A Masterwork of Art, a Metaphor for Prevention
Byron Breedlove et al. Volume 24, Number 7—July 2018 Registry Cohort Study to Determine Risk for Multiple Sclerosis after Vaccination for Pandemic Influenza A(H1N1) with Arepanrix, Manitoba, Canada
Salaheddin M. Mahmud et al. Volume 24, Number 7—July 2018 Podcast Progress and Remaining Gaps in Estimating the Global Disease Burden of Influenza
Joseph Bresee et al. Volume 24, Number 7—July 2018 presentation_01

Listen to the podcast Foot-and-Mouth Disease in the Middle East Caused by an A/ASIA/G-VII Virus Lineage, 2015–2016
Katarzyna Bachanek-Bankowska et al. Volume 24, Number 6—June 2018 Bimodal Seasonality and Alternating Predominance of Norovirus GII.4 and Non-GII.4, Hong Kong, China, 2014–2017
Martin Chi-Wai Chan et al. Volume 24, Number 4—April 2018 Genomic Surveillance of 4CMenB Vaccine Antigenic Variants among Disease-Causing Neisseria meningitidis Isolates, United Kingdom, 2010–2016
Charlene M.C. Rodrigues et al. Volume 24, Number 4—April 2018 Classical Swine Fever Outbreak after Modified Live LOM Strain Vaccination in Naive Pigs, South Korea
Sang H. Je et al. Volume 24, Number 4—April 2018 Capsule Typing of Haemophilus influenzae by Matrix-Assisted Laser Desorption/Ionization Time-of-Flight Mass Spectrometry
Viktor Månsson et al. Volume 24, Number 3—March 2018 Podcast Emergence of Streptococcus pneumoniae Serotype 12F after Sequential Introduction of 7- and 13-Valent Vaccines, Israel
Assaf Rokney et al. Volume 24, Number 3—March 2018 presentation_01

Listen to the podcast Influenza Vaccination and Incident Tuberculosis among Elderly Persons, Taiwan
Yung-Feng Yen et al. Volume 24, Number 3—March 2018 In the Company of Microbes: Ten Years of Small Things Considered
Richard Danila Volume 24, Number 2—February 2018 Trends in Infectious Disease Mortality, South Korea, 1983–2015
Young June Choe et al. Volume 24, Number 2—February 2018 Spread of Meropenem-Resistant Streptococcus pneumoniae Serotype 15A-ST63 Clone in Japan, 2012–2014
Satoshi Nakano et al. Volume 24, Number 2—February 2018 Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage
Liset Olarte et al. Volume 24, Number 2—February 2018 Epidemic Varicella Zoster Virus among University Students, India
Josh Meyers et al. Volume 24, Number 2—February 2018 Investigation of Canine-Mediated Human Rabies Death, Haiti, 2015
Cuc H. Tran et al. Volume 24, Number 1—January 2018 Emergence of Vaccine-Derived Polioviruses during Ebola Virus Disease Outbreak, Guinea, 2014–2015
Maria Dolores Fernandez-Garcia et al. Volume 24, Number 1—January 2018

2017

Podcast US Centers for Disease Control and Prevention and Its Partners’ Contributions to Global Health Security
Jordan W. Tappero et al. Volume 23, Supplement—December 2017 presentation_01

Listen to the podcast Expanding Pertussis Epidemiology in 6 Latin America Countries through the Latin American Pertussis Project
Veronica A. Pinell-McNamara et al. Volume 23, Supplement—December 2017 Enhancing Workforce Capacity to Improve Vaccination Data Quality, Uganda
Kirsten Ward et al. Volume 23, Supplement—December 2017 Lessons Learned from Emergency Response Vaccination Efforts for Cholera, Typhoid, Yellow Fever, and Ebola
Jenny A. Walldorf et al. Volume 23, Supplement—December 2017 Lineage-Specific Real-Time RT-PCR for Yellow Fever Virus Outbreak Surveillance, Brazil
Carlo Fischer et al. Volume 23, Number 11—November 2017 Emergence of Bordetella holmesii as a Causative Agent of Whooping Cough, Barcelona, Spain
Alba Mir-Cros et al. Volume 23, Number 11—November 2017 Poliovirus Excretion in Children with Primary Immunodeficiency Disorders, India
Madhu Chhanda Mohanty et al. Volume 23, Number 10—October 2017 Identification of Clade E Avipoxvirus, Mozambique, 2016
Lourenço P. Mapaco et al. Volume 23, Number 9—September 2017 Human Metapneumovirus and Other Respiratory Viral Infections during Pregnancy and Birth, Nepal
Jennifer L. Lenahan et al. Volume 23, Number 8—August 2017 Risk for Death among Children with Pneumonia, Afghanistan
Rahmani Zabihullah et al. Volume 23, Number 8—August 2017 Emergency Meningococcal ACWY Vaccination Program for Teenagers to Control Group W Meningococcal Disease, England, 2015–2016
Helen Campbell et al. Volume 23, Number 7—July 2017 Clinical and Molecular Characteristics of Human Rotavirus G8P[8] Outbreak Strain, Japan, 2014
Kenji Kondo et al. Volume 23, Number 6—June 2017 Invasive Serotype 35B Pneumococci Including an Expanding Serotype Switch Lineage, United States, 2015–2016
Sopio Chochua et al. Volume 23, Number 6—June 2017 Rise in Group W Meningococcal Carriage in University Students, United Kingdom
Neil J. Oldfield et al. Volume 23, Number 6—June 2017 Penicillin Resistance of Nonvaccine Type Pneumococcus before and after PCV13 Introduction, United States
Cheryl P. Andam et al. Volume 23, Number 6—June 2017 Podcast Prevention of Chronic Hepatitis B after 3 Decades of Escalating Vaccination Policy, China
Fuqiang Cui et al. Volume 23, Number 5—May 2017 presentation_01

Listen to the podcast Serogroup B Meningococcal Disease Vaccine Recommendations at a University, New Jersey, USA, 2016
Heidi M. Soeters et al. Volume 23, Number 5—May 2017 Lack of Durable Cross-Neutralizing Antibodies Against Zika Virus from Dengue Virus Infection
Matthew H. Collins et al. Volume 23, Number 5—May 2017 Neurologic Complications of Influenza B Virus Infection in Adults, Romania
Corneliu P. Popescu et al. Volume 23, Number 4—April 2017 Biologic Evidence Required for Zika Disease Enhancement by Dengue Antibodies
Scott B. Halstead Volume 23, Number 4—April 2017 Serologic Evidence for MERS-CoV Infection in Dromedary Camels, Punjab, Pakistan, 2012–2015
Muhammad Saqib et al. Volume 23, Number 3—March 2017 Epidemiology of Invasive Haemophilus influenzae Disease, Europe, 2007–2014
Robert Whittaker et al. Volume 23, Number 3—March 2017 Estimated Effect of Inactivated Poliovirus Vaccine Campaigns, Nigeria and Pakistan, January 2014–April 2016
George Shirreff et al. Volume 23, Number 2—February 2017 Changing Epidemiology of Hepatitis A and Hepatitis E Viruses in China, 1990–2014
Xiang Ren et al. Volume 23, Number 2—February 2017 Acute Respiratory Disease in US Army Trainees 3 Years after Reintroduction of Adenovirus Vaccine
Nakia S. Clemmons et al. Volume 23, Number 1—January 2017 Haemophilus influenzae Type b Invasive Disease in Amish Children, Missouri, USA, 2014
Angela L. Myers et al. Volume 23, Number 1—January 2017 Oral Cholera Vaccine Coverage during an Outbreak and Humanitarian Crisis, Iraq, 2015
Eugene Lam et al. Volume 23, Number 1—January 2017 Increased Invasive Pneumococcal Disease, North East England, UK
Catherine Houseman et al. Volume 23, Number 1—January 2017

2016

Time Course of MERS-CoV Infection and Immunity in Dromedary Camels
Benjamin Meyer et al. Volume 22, Number 12—December 2016 African Horse Sickness Caused by Genome Reassortment and Reversion to Virulence of Live, Attenuated Vaccine Viruses, South Africa, 2004–2014
Camilla Weyer et al. Volume 22, Number 12—December 2016 Anomalous High Rainfall and Soil Saturation as Combined Risk Indicator of Rift Valley Fever Outbreaks, South Africa, 2008–2011
Roy Williams et al. Volume 22, Number 12—December 2016 Dog-Mediated Human Rabies Death, Haiti, 2016
Ryan M. Wallace et al. Volume 22, Number 11—November 2016 Meningococcal Disease in US Military Personnel before and after Adoption of Conjugate Vaccine
Michael D. Decker Volume 22, Number 11—November 2016 Vaccine-Derived Polioviruses and Children with Primary Immunodeficiency, Iran, 1995–2014
Mohammadreza Shaghaghi et al. Volume 22, Number 10—October 2016 Reemergence of Japanese Encephalitis in South Korea, 2010–2015
Jun-Sang Sunwoo et al. Volume 22, Number 10—October 2016 Population-Level Effects of Human Papillomavirus Vaccination Programs on Infections with Nonvaccine Genotypes
David Mesher et al. Volume 22, Number 10—October 2016 Yellow Fever—More a Policy and Planning Problem than a Biological One
Charles H. Calisher et al. Volume 22, Number 10—October 2016 Feasibility of Using Convalescent Plasma Immunotherapy for MERS-CoV Infection, Saudi Arabia
Yaseen M. Arabi et al. Volume 22, Number 9—September 2016 Toward Developing a Preventive MERS-CoV Vaccine—Report from a Workshop Organized by the Saudi Arabia Ministry of Health and the International Vaccine Institute, Riyadh, Saudi Arabia, November 14–15, 2015
Jean-Louis Excler et al. Volume 22, Number 8—August 2016 Meningococcal Group W Disease in Infants and Potential Prevention by Vaccination
Sydel R. Parikh et al. Volume 22, Number 8—August 2016 Development of Medical Countermeasures to Middle East Respiratory Syndrome Coronavirus
Timothy M. Uyeki et al. Volume 22, Number 7—July 2016 Yellow Fever in a Worker Returning to China from Angola, March 2016
Yun Ling et al. Volume 22, Number 7—July 2016 Postbooster Antibodies from Humans as Source of Diphtheria Antitoxin
Jesús F. Bermejo-Martin et al. Volume 22, Number 7—July 2016 Ecologic Study of Meningococcal B Vaccine and Neisseria gonorrhoeae Infection, Norway
Jane Whelan et al. Volume 22, Number 6—June 2016 Experimental Infection and Response to Rechallenge of Alpacas with Middle East Respiratory Syndrome Coronavirus
Gary Crameri et al. Volume 22, Number 6—June 2016 MERS-CoV Antibodies in Humans, Africa, 2013–2014
Anne M. Liljander et al. Volume 22, Number 6—June 2016 Post-Ebola Measles Outbreak in Lola, Guinea, January–June 2015
Jonathan E. Suk et al. Volume 22, Number 6—June 2016 Population-Level Effect of Cholera Vaccine on Displaced Populations, South Sudan, 2014
Andrew S. Azman et al. Volume 22, Number 6—June 2016 Changes in Childhood Pneumonia Hospitalizations by Race and Sex Associated with Pneumococcal Conjugate Vaccines
Andrew D. Wiese et al. Volume 22, Number 6—June 2016 Crimean-Congo Hemorrhagic Fever Virus IgG in Goats, Bhutan
Sonam Wangchuk et al. Volume 22, Number 5—May 2016 Avian Influenza A(H5N1) Virus in Egypt
Ghazi Kayali et al. Volume 22, Number 3—March 2016 Suspected Rabies in Humans and Animals, Laikipia County, Kenya
Mark Obonyo et al. Volume 22, Number 3—March 2016 Sustained Transmission of Pertussis in Vaccinated, 1–5-Year-Old Children in a Preschool, Florida, USA
James Matthias et al. Volume 22, Number 2—February 2016 Epidemiology of Serotype 1 Invasive Pneumococcal Disease, South Africa, 2003–2013
Claire von Mollendorf et al. Volume 22, Number 2—February 2016 Effectiveness of Meningococcal B Vaccine against Endemic Hypervirulent Neisseria meningitidis W Strain, England
Shamez Ladhani et al. Volume 22, Number 2—February 2016 Human Papillomavirus Prevalence and Herd Immunity after Introduction of Vaccination Program, Scotland, 2009–2013
Ross L. Cameron et al. Volume 22, Number 1—January 2016 Effectiveness of Ring Vaccination as Control Strategy for Ebola Virus Disease
Adam J. Kucharski et al. Volume 22, Number 1—January 2016 Human Papillomavirus Vaccination at a Time of Changing Sexual Behavior
Iacopo Baussano et al. Volume 22, Number 1—January 2016 Hemagglutinin Gene Clade 3C.2a Influenza A(H3N2) Viruses, Alachua County, Florida, USA, 2014–15
John Lednicky et al. Volume 22, Number 1—January 2016 Measles Outbreak among Adults, Northeastern China, 2014
Ming-Xiang Zhang et al. Volume 22, Number 1—January 2016

2015

The Fantastic Laboratory of Dr. Weigl: How Two Brave Scientists Battled Typhus and Sabotaged the Nazis
Chong-Gee Teo Volume 21, Number 11—November 2015 Invasive Salmonella Discussed in Africa Consensus Meeting 2014, Blantyre, Malawi
Robert S. Heyderman et al. Volume 21, Number 11—November 2015 Invasive Pneumococcal Disease 3 Years after Introduction of 10-Valent Pneumococcal Conjugate Vaccine, the Netherlands
Mirjam J. Knol et al. Volume 21, Number 11—November 2015 Pneumococcal Infection among Children before Introduction of 13-Valent Pneumococcal Conjugate Vaccine, Cambodia
Paul Turner et al. Volume 21, Number 11—November 2015 Serogroup W Meningitis Outbreak at the Subdistrict Level, Burkina Faso, 2012
Laurence Cibrelus et al. Volume 21, Number 11—November 2015 Serotype Changes and Drug Resistance in Invasive Pneumococcal Diseases in Adults after Vaccinations in Children, Japan, 2010–2013
Kimiko Ubukata et al. Volume 21, Number 11—November 2015 Economic Costs of Measles Outbreak in the Netherlands, 2013–2014
Anita W.M. Suijkerbuijk et al. Volume 21, Number 11—November 2015 Podcast Invasive Disease Caused by Nontypeable Haemophilus influenzae
Jeroen D. Langereis et al. Volume 21, Number 10—October 2015 presentation_01

Listen to the podcast Vaccine-Derived Polioviruses Not Detected by Global Surveillance Screening Assay
Deepa K. Sharma et al. Volume 21, Number 10—October 2015 Risk Factors for Sustained Cholera Transmission, Juba County, South Sudan, 2014
Thomas T.A. Ujjiga et al. Volume 21, Number 10—October 2015 Tracking Pertussis and Evaluating Control Measures through Enhanced Pertussis Surveillance, Emerging Infections Program, United States
Tami H. Skoff et al. Volume 21, Number 9—September 2015 Monitoring Effect of Human Papillomavirus Vaccines in US Population, Emerging Infections Program, 2008–2012
Susan Hariri et al. Volume 21, Number 9—September 2015 Increase in Lymphadenitis Cases after Shift in BCG Vaccine Strain
Giorgi Kuchukhidze et al. Volume 21, Number 9—September 2015 Smallpox Vaccination of Laboratory Workers at US Variola Testing Sites
Sharon Medcalf et al. Volume 21, Number 8—August 2015 Measles Vaccination Coverage and Cases among Vaccinated Persons
Christian L. Althaus et al. Volume 21, Number 8—August 2015 Response Strategies against Meningitis Epidemics after Elimination of Serogroup A Meningococci, Niger
Halima Boubacar Maïnassara et al. Volume 21, Number 8—August 2015 Determination of Predominance of Influenza Virus Strains in the Americas
Eduardo Azziz-Baumgartner et al. Volume 21, Number 7—July 2015 Oral Cholera Vaccine Coverage, Barriers to Vaccination, and Adverse Events following Vaccination, Haiti, 2013
Rania A. Tohme et al. Volume 21, Number 6—June 2015 Podcast Cost-effectiveness of Chlamydia Vaccination Programs for Young Women
Kwame Owusu-Edusei et al. Volume 21, Number 6—June 2015 presentation_01

Listen to the podcast Induction of Influenza (H5N8) Antibodies by Modified Vaccinia Virus Ankara H5N1 Vaccine
Rory D. de Vries et al. Volume 21, Number 6—June 2015 Consensus on the Development of Vaccines against Naturally Acquired Melioidosis
Direk Limmathurotsakul et al. Volume 21, Number 6—June 2015 Getah Virus Infection among Racehorses, Japan, 2014
Manabu Nemoto et al. Volume 21, Number 5—May 2015 Safety of Recombinant VSV–Ebola Virus Vaccine Vector in Pigs
Emmie de Wit et al. Volume 21, Number 4—April 2015 Increased Risk for Group B Streptococcus Sepsis in Young Infants Exposed to HIV, Soweto, South Africa, 2004–2008
Clare L. Cutland et al. Volume 21, Number 4—April 2015 Risk Factors for Death from Invasive Pneumococcal Disease, Europe, 2010
Adoración Navarro-Torné et al. Volume 21, Number 3—March 2015 Mycobacterium bovis BCG–Associated Osteomyelitis/Osteitis, Taiwan
Nan-Chang Chiu et al. Volume 21, Number 3—March 2015 Etymologia: M. bovis
Volume 21, Number 3—March 2015 Comparative Analysis of African Swine Fever Virus Genotypes and Serogroups
Alexander Malogolovkin et al. Volume 21, Number 2—February 2015 Vesicular Stomatitis Virus–Based Vaccines against Lassa and Ebola Viruses
Andrea Marzi et al. Volume 21, Number 2—February 2015 Naturally Acquired Antibodies against Haemophilus influenzae Type a in Aboriginal Adults, Canada
Eli B. Nix et al. Volume 21, Number 2—February 2015 Meningococcal Disease in US Military Personnel before and After Adoption of Conjugate Vaccine
Michael P. Broderick et al. Volume 21, Number 2—February 2015 Continuing Effectiveness of Serogroup A Meningococcal Conjugate Vaccine, Chad, 2013
Kadidja Gamougam et al. Volume 21, Number 1—January 2015

2014

Subclinical Highly Pathogenic Avian Influenza Virus Infection among Vaccinated Chickens, China
Qing-Xia Ma et al. Volume 20, Number 12—December 2014 Vaccine-Induced Waning of Haemophilus influenzae Empyema and Meningitis, Angola
Heikki Peltola et al. Volume 20, Number 11—November 2014 Risk Factors for Severe Influenza A–Related Pneumonia in Adult Cohort, Mexico, 2013–14
Alejandro Gómez-Gómez et al. Volume 20, Number 9—September 2014 Cerebellitis Associated with Influenza A(H1N1)pdm09, United States, 2013
Maroun M. Sfeir et al. Volume 20, Number 9—September 2014 Changes in Capsule and Drug Resistance of Pneumococci after Introduction of PCV7, Japan, 2010–2013
Naoko Chiba et al. Volume 20, Number 7—July 2014 Carriage Rate and Effects of Vaccination after Outbreaks of Serogroup C Meningococcal Disease, Brazil, 2010
Marco Aurelio Palazzi Sáfadi et al. Volume 20, Number 5—May 2014 Schmallenberg Virus Antibodies in Adult Cows and Maternal Antibodies in Calves
Armin R.W. Elbers et al. Volume 20, Number 5—May 2014 Rapid Increase in Pertactin-deficient Bordetella pertussis Isolates, Australia
Connie Lam et al. Volume 20, Number 4—April 2014 Epidemic of Mumps among Vaccinated Persons, the Netherlands, 2009–2012
Jussi Sane et al. Volume 20, Number 4—April 2014 Efficiency of Points of Dispensing for Influenza A(H1N1)pdm09 Vaccination, Los Angeles County, California, USA, 2009
Shubhayu Saha et al. Volume 20, Number 4—April 2014 Etymologia: Pertactin
Volume 20, Number 4—April 2014 Regional Variation in Travel-related Illness acquired in Africa, March 1997–May 2011
Marc Mendelson et al. Volume 20, Number 4—April 2014 Distribution of Pandemic Influenza Vaccine and Reporting of Doses Administered, New York, New York, USA
Roopa Kalyanaraman Marcello et al. Volume 20, Number 4—April 2014 Hendra Virus Vaccine, a One Health Approach to Protecting Horse, Human, and Environmental Health
Deborah Middleton et al. Volume 20, Number 3—March 2014 Neisseria meningitidis Serogroup W, Burkina Faso, 2012
Jessica R. MacNeil et al. Volume 20, Number 3—March 2014 Special Considerations for Prophylaxis for and Treatment of Anthrax in Pregnant and Postpartum Women
Dana Meaney-Delman et al. Volume 20, Number 2—February 2014 Seven-Valent Pneumococcal Conjugate Vaccine and Nasopharyngeal Microbiota in Healthy Children
Giske Biesbroek et al. Volume 20, Number 2—February 2014 Resolution of Novel Human Papillomavirus–induced Warts after HPV Vaccination
Steffi Silling et al. Volume 20, Number 1—January 2014 Dynamic Modeling of Cost-effectiveness of Rotavirus Vaccination, Kazakhstan
Birgitte Freiesleben de Blasio et al. Volume 20, Number 1—January 2014

2013

Guillain-Barré Syndrome Surveillance during National Influenza Vaccination Campaign, New York, USA, 2009
Gregory P. Giambrone et al. Volume 19, Number 12—December 2013 Pseudorabies Virus Variant in Bartha-K61–Vaccinated Pigs, China, 2012
Tong-Qing An et al. Volume 19, Number 11—November 2013 Evidence of Vaccine-related Reassortment of Rotavirus, Brazil, 2008–2010
Tatiana Lundgren Rose et al. Volume 19, Number 11—November 2013 Emergence of Vaccine-derived Polioviruses, Democratic Republic of Congo, 2004–2011
Nicksy Gumede et al. Volume 19, Number 10—October 2013 Ongoing Measles Outbreak in Orthodox Jewish Community, London, UK
Vanessa Baugh et al. Volume 19, Number 10—October 2013 Clinical Profile of Children with Norovirus Disease in Rotavirus Vaccine Era
Mary E. Wikswo et al. Volume 19, Number 10—October 2013 Mumps Postexposure Prophylaxis with a Third Dose of Measles-Mumps-Rubella Vaccine, Orange County, New York, USA
Amy Parker Fiebelkorn et al. Volume 19, Number 9—September 2013 Call to Action for Dengue Vaccine Failure
Suresh Mahalingam et al. Volume 19, Number 8—August 2013 Detection of Novel Rotavirus Strain by Vaccine Postlicensure Surveillance
Geoffrey A. Weinberg et al. Volume 19, Number 8—August 2013 Duration of Immunity to Norovirus Gastroenteritis
Kirsten Simmons et al. Volume 19, Number 8—August 2013 Influence of Pneumococcal Vaccines and Respiratory Syncytial Virus on Alveolar Pneumonia, Israel
Daniel M. Weinberger et al. Volume 19, Number 7—July 2013 Pneumococcal Serotypes before and after Introduction of Conjugate Vaccines, United States, 1999–2011
Sandra S. Richter et al. Volume 19, Number 7—July 2013 Rifampin-Resistant Mycobacterium bovis BCG–Induced Disease in HIV-Infected Infant, Vietnam
Duc Nguyen Hong et al. Volume 19, Number 7—July 2013 Wild Poliovirus Importation, Central African Republic
Ionela Gouandjika-Vasilache et al. Volume 19, Number 6—June 2013 Reemergence of Recombinant Vaccine–derived Polioviruses in Healthy Children, Madagascar
Richter Razafindratsimandresy et al. Volume 19, Number 6—June 2013 In Memoriam: Alexander I. Klimov (1943–2013)
Brian W.J. Mahy Volume 19, Number 5—May 2013 Changes in Severity of Influenza A(H1N1)pdm09 Infection from Pandemic to First Postpandemic Season, Germany
Nicola Lehners et al. Volume 19, Number 5—May 2013 Podcast Myth Dispelled
Adam Possner Volume 19, Number 4—April 2013 presentation_01

Listen to the podcast Effect of 10-Valent Pneumococcal Vaccine on Pneumonia among Children, Brazil
Eliane Terezinha Afonso et al. Volume 19, Number 4—April 2013 Pale horse, pale rider done taken my lover away
Polyxeni Potter Volume 19, Number 4—April 2013 Risk Factors for Influenza among Health Care Workers during 2009 Pandemic, Toronto, Ontario, Canada
Stefan P. Kuster et al. Volume 19, Number 4—April 2013 Measles Elimination Efforts and 2008–2011 Outbreak, France
Denise Antona et al. Volume 19, Number 3—March 2013 Virulence of Pertactin-Negative Bordetella pertussis Isolates from Infants, France
Hélène Bodilis et al. Volume 19, Number 3—March 2013 Effects of Vaccine Program against Pandemic Influenza A(H1N1) Virus, United States, 2009–2010
Rebekah H. Borse et al. Volume 19, Number 3—March 2013 Lessons and Challenges for Measles Control from Unexpected Large Outbreak, Malawi
Andrea Minetti et al. Volume 19, Number 2—February 2013 Kyasanur Forest Disease, India, 2011–2012
Gudadappa S. Kasabi et al. Volume 19, Number 2—February 2013 Rinderpest Virus Sequestration and Use in Posteradication Era
Guillaume Fournié et al. Volume 19, Number 1—January 2013

2012

Lack of Cross-protection against Bordetella holmesii after Pertussis Vaccination
Xuqing Zhang et al. Volume 18, Number 11—November 2012 Invasive Pneumococcal Disease and 7-Valent Pneumococcal Conjugate Vaccine, the Netherlands
Anna M.M. van Deursen et al. Volume 18, Number 11—November 2012 Call to Action on World Pneumonia Day
Rana Hajjeh et al. Volume 18, Number 11—November 2012 Trends in Meningococcal Disease in the United States Military, 1971–2010
Michael P. Broderick et al. Volume 18, Number 9—September 2012 Podcast Hepatitis E, a Vaccine-Preventable Cause of Maternal Deaths
Alain B. Labrique et al. Volume 18, Number 9—September 2012 presentation_01

Listen to the podcast Inadequate Antibody Response to Rabies Vaccine in Immunocompromised Patient
Eran Kopel et al. Volume 18, Number 9—September 2012 Population Diversity among Bordetella pertussis Isolates, United States, 1935–2009
Amber J. Schmidtke et al. Volume 18, Number 8—August 2012 Considerations for Oral Cholera Vaccine Use during Outbreak after Earthquake in Haiti, 2010–2011
Kashmira Date et al. Volume 18, Number 7—July 2012 Lessons Learned from Influenza A(H1N1)pdm09 Pandemic Response in Thailand
Kumnuan Ungchusak et al. Volume 18, Number 7—July 2012 Immunodeficiency-associated Vaccine-Derived Poliovirus Type 3 in Infant, South Africa, 2011
Nicksy Gumede et al. Volume 18, Number 6—June 2012 No Association between 2008–09 Influenza Vaccine and Influenza A(H1N1)pdm09 Virus Infection, Manitoba, Canada, 2009
Salaheddin M. Mahmud et al. Volume 18, Number 5—May 2012 Podcast Adenovirus-associated Deaths in US Military during Postvaccination Period, 1999–2010
Robert N. Potter et al. Volume 18, Number 3—March 2012 presentation_01

Listen to the podcast Accelerating Control of Pertussis in England and Wales
Helen Campbell et al. Volume 18, Number 1—January 2012 Mumps Vaccine Effectiveness Against Orchitis
Susan Hahné et al. Volume 18, Number 1—January 2012 Modeling Insights into Haemophilus influenzae Type b Disease, Transmission, and Vaccine Programs
Michael L. Jackson et al. Volume 18, Number 1—January 2012 Podcast Invasive Meningococcal Capsular Group Y Disease, England and Wales, 2007–2009
Shamez N. Ladhani et al. Volume 18, Number 1—January 2012 presentation_01

Listen to the podcast

2011

Candidate Cell Substrates, Vaccine Production, and Transmissible Spongiform Encephalopathies
Pedro Piccardo et al. Volume 17, Number 12—December 2011 Considerations for Oral Cholera Vaccine Use during Outbreak after Earthquake in Haiti, 2010−2011
Kashmira A. Date et al. Volume 17, Number 11—November 2011 Yellow Fever Virus Vaccine–associated Deaths in Young Women
Stephen J. Seligman Volume 17, Number 10—October 2011 Bacterial Causes of Empyema in Children, Australia, 2007–2009
Roxanne E. Strachan et al. Volume 17, Number 10—October 2011 Carriage of Meningococci by University Students, United Kingdom
Dlawer A.A. Ala’Aldeen et al. Volume 17, Number 9—September 2011 Rift Valley Fever Vaccine Development, Progress and Constraints
Jeroen Kortekaas et al. Volume 17, Number 9—September 2011 Increasing Incidence of Invasive Haemophilus influenzae Disease in Adults, Utah, USA
Matthew P. Rubach et al. Volume 17, Number 9—September 2011 Seroepidemiologic Study of Pandemic (H1N1) 2009 during Outbreak in Boarding School, England
Sandra Johnson et al. Volume 17, Number 9—September 2011 Pandemic (H1N1) 2009 and Hajj Pilgrims Who Received Predeparture Vaccination, Egypt
Amr Kandeel et al. Volume 17, Number 7—July 2011 Podcast Invasive Group A Streptococcal Infection and Vaccine Implications, Auckland, New Zealand
Atheer Safar et al. Volume 17, Number 6—June 2011 presentation_01

Listen to the podcast Community Vaccinators in the Workplace
Jeffrey R. Harris et al. Volume 17, Number 6—June 2011 Podcast The Crab Hole Mosquito Blues
Karl M. Johnson et al. Volume 17, Number 5—May 2011 presentation_01

Listen to the podcast Genome Sequence of SG33 Strain and Recombination between Wild-Type and Vaccine Myxoma Viruses
Christelle Camus-Bouclainville et al. Volume 17, Number 4—April 2011 Hepatitis A Virus Vaccine Escape Variants and Potential New Serotype Emergence
Unai Pérez-Sautu et al. Volume 17, Number 4—April 2011 Edward Jenner Museum
William Foege Volume 17, Number 4—April 2011 Podcast Vaccinia Virus Infections in Martial Arts Gym, Maryland, USA, 2008
Christine M. Hughes et al. Volume 17, Number 4—April 2011 presentation_01

Listen to the podcast Bacterial Meningitis and Haemophilus influenzae Type b Conjugate Vaccine, Malawi
David W. McCormick et al. Volume 17, Number 4—April 2011 Carriage of Streptococcus pneumoniae 3 Years after Start of Vaccination Program, the Netherlands
Judith Spijkerman et al. Volume 17, Number 4—April 2011 Remaining Questions about Clinical Variola Major
J. Michael Lane Volume 17, Number 4—April 2011 Etymologia: Variola and Vaccination
Nancy Männikkö Volume 17, Number 4—April 2011 Effects of Vaccination against Pandemic (H1N1) 2009 among Japanese Children
Hiroshi Nishiura et al. Volume 17, Number 4—April 2011 Reduction of Coxiella burnetii Prevalence by Vaccination of Goats and Sheep, the Netherlands
Lenny Hogerwerf et al. Volume 17, Number 3—March 2011 Serotype Distribution and Drug Resistance in Streptococcus pneumoniae, Palestinian Territories
Randa Kattan et al. Volume 17, Number 1—January 2011 Serologic Status for Pandemic (H1N1) 2009 Virus, Taiwan
Daniel Tsung-Ning Huang et al. Volume 17, Number 1—January 2011

2010

Decreasing Shigellosis-related Deaths without Shigella spp.–specific Interventions, Asia
Pradip Bardhan et al. Volume 16, Number 11—November 2010 Pediatric Pneumococcal Serotypes in 4 European Countries
Germaine Hanquet et al. Volume 16, Number 9—September 2010 Pearl Kendrick, Grace Eldering, and the Pertussis Vaccine
Carolyn G. Shapiro-Shapin Volume 16, Number 8—August 2010 Postexposure Treatment of Marburg Virus Infection
Thomas W. Geisbert et al. Volume 16, Number 7—July 2010 Podcast Vaccine-associated Paralytic Poliomyelitis in Immunodeficient Children, Iran, 1995–2008
Shohreh Shahmahmoodi et al. Volume 16, Number 7—July 2010 presentation_01

Listen to the podcast Original Antigenic Sin and Pandemic (H1N1) 2009
Amesh A. Adalja et al. Volume 16, Number 6—June 2010 Increase in Pilus Islet 2–encoded Pili among Streptococcus pneumoniae Isolates, Atlanta, Georgia, USA
Dorothea Zähner et al. Volume 16, Number 6—June 2010 Swine Influenza A Vaccines, Pandemic (H1N1) 2009 Virus, and Cross-Reactivity
Ralf Dürrwald et al. Volume 16, Number 6—June 2010 The Wages of Original Antigenic Sin
David M. Morens et al. Volume 16, Number 6—June 2010 Cross-Reactive Antibodies to Pandemic (H1N1) 2009 Virus, Singapore
Julian W. Tang et al. Volume 16, Number 5—May 2010 Effects of Pneumococcal Conjugate Vaccine 2 Years after Its Introduction, the Netherlands
Gerwin D. Rodenburg et al. Volume 16, Number 5—May 2010 Alfred Russel Wallace and the Antivaccination Movement in Victorian England
Thomas P. Weber Volume 16, Number 4—April 2010 Pandemic (H1N1) 2009 Risk for Nurses after Trivalent Vaccination
Mark B. Loeb et al. Volume 16, Number 4—April 2010 Denialism: How Irrational Thinking Hinders Scientific Progress, Harms the Planet, and Threatens Our Lives
Tara C. Smith Volume 16, Number 4—April 2010 Podcast Invasive Haemophilus influenzae Disease, Europe, 1996–2006
Shamez Ladhani et al. Volume 16, Number 3—March 2010 presentation_01

Listen to the podcast Vaccine Preventability of Meningococcal Clone, Greater Aachen Region, Germany
Johannes Elias et al. Volume 16, Number 3—March 2010 Statewide School-located Influenza Vaccination Program for Children 5–13 Years of Age, Hawaii, USA
Paul V. Effler et al. Volume 16, Number 2—February 2010 Cost-effectiveness of Pharmaceutical-based Pandemic Influenza Mitigation Strategies
Anthony T. Newall et al. Volume 16, Number 2—February 2010 Clonal Distribution of Invasive Pneumococci, Czech Republic, 1996–2003
Helena Žemličková et al. Volume 16, Number 2—February 2010 Bordetella pertussis Clones Identified by Multilocus Variable-Number Tandem-Repeat Analysis
Jacob Kurniawan et al. Volume 16, Number 2—February 2010 Healthcare-associated Viral Gastroenteritis among Children in a Large Pediatric Hospital, United Kingdom
Nigel A. Cunliffe et al. Volume 16, Number 1—January 2010 Increase in Serotype 6C Pneumococcal Carriage, United Kingdom
Anna S. Tocheva et al. Volume 16, Number 1—January 2010

2009

Low Immunity to Measles and Rubella among Female Guest Workers, Northern Mariana Islands
Vicki Stambos et al. Volume 15, Number 11—November 2009 Public Health Response to Imported Case of Poliomyelitis, Australia, 2007
John A. Carnie et al. Volume 15, Number 11—November 2009 Health Status of Visitors and Temporary Residents, United States
Emad A. Yanni et al. Volume 15, Number 11—November 2009 Transmission of Varicella Vaccine Virus, Japan
Taketo Otsuka et al. Volume 15, Number 10—October 2009 Genetic Characterization of Foot-and-Mouth Disease Viruses, Ethiopia, 1981–2007
Gelagay Ayelet et al. Volume 15, Number 9—September 2009 Reproducibility of Serologic Assays for Influenza Virus A (H5N1)
Iain Stephenson et al. Volume 15, Number 8—August 2009 Past, Present, and Future of Japanese Encephalitis
Susan L. Hills et al. Volume 15, Number 8—August 2009 Reemerging Rabies and Lack of Systemic Surveillance in People’s Republic of China
Xianfu Wu et al. Volume 15, Number 8—August 2009 Vaccine-induced Immunity Circumvented by Typical Mycobacterium tuberculosis Beijing Strains
Kristin Kremer et al. Volume 15, Number 2—February 2009 Chikungunya Virus and Central Nervous System Infections in Children, India
Penny Lewthwaite et al. Volume 15, Number 2—February 2009 Rotavirus Genotype Distribution after Vaccine Introduction, Rio de Janeiro, Brazil
Filipe Anibal Carvalho-Costa et al. Volume 15, Number 1—January 2009 Parapneumonic Empyema Deaths during Past Century, Utah
Jeffrey M. Bender et al. Volume 15, Number 1—January 2009

2008

A Prospective Study of Etiology of Childhood Acute Bacterial Meningitis, Turkey
Mehmet Ceyhan et al. Volume 14, Number 7—July 2008 Pertussis Surveillance in Private Pediatric Practices, France, 2002–2006
Nicole Guiso et al. Volume 14, Number 7—July 2008 Persistence of Diphtheria, Hyderabad, India, 2003–2006
Sailaja Bitragunta et al. Volume 14, Number 7—July 2008 Major Issues and Challenges of Influenza Pandemic Preparedness in Developing Countries
Hitoshi Oshitani et al. Volume 14, Number 6—June 2008 Control of Hepatitis A by Universal Vaccination of Adolescents, Puglia, Italy
Pietro Luigi Lopalco et al. Volume 14, Number 3—March 2008 Streptococcus pneumoniae Serotype 19A in Children, South Korea
Eun Hwa Choi et al. Volume 14, Number 2—February 2008 Effectiveness of Personal Protective Measures to Prevent Lyme Disease
Marietta Vázquez et al. Volume 14, Number 2—February 2008 Cost-effectiveness of Human Papillomavirus Vaccination in the United States
Harrell W. Chesson et al. Volume 14, Number 2—February 2008 Invasive Bacterial Diseases in Northern Canada
Naushaba Degani et al. Volume 14, Number 1—January 2008 Pandemic Influenza and Pregnant Women
Sonja A. Rasmussen et al. Volume 14, Number 1—January 2008 Influenza Virus Samples, International Law, and Global Health Diplomacy
David P. Fidler Volume 14, Number 1—January 2008

2007

Human Papillomavirus Vaccination Strategies
Santiago Pérez Cachafeiro Volume 13, Number 12—December 2007 Viable Newcastle Disease Vaccine Strains in a Pharmaceutical Dump
Antonella Amendola et al. Volume 13, Number 12—December 2007 Rabies Prophylaxis for Pregnant Women
Mohamed E. Abazeed et al. Volume 13, Number 12—December 2007 AIDS Vaccine Development: Challenges and Opportunities
Robert T. Chen Volume 13, Number 11—November 2007 Confronting Potential Influenza A (H5N1) Pandemic with Better Vaccines
Azizul Haque et al. Volume 13, Number 10—October 2007 Predominance of Rotavirus P[4]G2 in a Vaccinated Population, Brazil
Ricardo Q. Gurgel et al. Volume 13, Number 10—October 2007 Inactivated Whole Virus Influenza A (H5N1) Vaccine
Zoltan Vajo et al. Volume 13, Number 5—May 2007 Influenza Vaccine Effectiveness among US Military Basic Trainees, 2005–06 Season
Jennifer K. Strickler et al. Volume 13, Number 4—April 2007 Matrix Protein 2 Vaccination and Protection against Influenza Viruses, Including Subtype H5N1
Stephen Mark Tompkins et al. Volume 13, Number 3—March 2007 New Strain of Influenza A Virus (H5N1), Thailand
Salin Chutinimitkul et al. Volume 13, Number 3—March 2007 Vaccine Effectiveness Estimates, 2004–2005 Mumps Outbreak, England
Cheryl Cohen et al. Volume 13, Number 1—January 2007 Model for Assessing Human Papillomavirus Vaccination Strategies
Elamin H. Elbasha et al. Volume 13, Number 1—January 2007

2006

Prophylaxis and Treatment of Pregnant Women for Emerging Infections and Bioterrorism Emergencies
Joanne Cono et al. Volume 12, Number 11—November 2006 Chimpanzee Adenovirus Antibodies in Humans, Sub-Saharan Africa
Zhiquan Xiang et al. Volume 12, Number 10—October 2006 Critical Issues in Responding to Pandemic Influenza
James W. Buehler et al. Volume 12, Number 7—July 2006 Haemophilus influenzae Type b Reemergence after Combination Immunization
Nik G. Johnson et al. Volume 12, Number 6—June 2006 Lack of Transmission of Vaccinia Virus
James H. Stark et al. Volume 12, Number 4—April 2006 Human Influenza Surveillance: the Demand to Expand
Scott P. Layne Volume 12, Number 4—April 2006 Prospects for Universal Influenza Virus Vaccine
Walter Gerhard et al. Volume 12, Number 4—April 2006 Structural Biology of Bacterial Pathogenesis
Dennis Stevens Volume 12, Number 2—February 2006 Vaccines and Antiviral Drugs in Pandemic Preparedness
Arnold S. Monto Volume 12, Number 1—January 2006 Cell-mediated Protection in Influenza Infection
Paul G. Thomas et al. Volume 12, Number 1—January 2006 Making Better Influenza Virus Vaccines?
Peter Palese Volume 12, Number 1—January 2006 Pandemic Influenza Threat and Preparedness
Anthony S. Fauci Volume 12, Number 1—January 2006 H5N1 Outbreaks and Enzootic Influenza
Robert G. Webster et al. Volume 12, Number 1—January 2006 Influenza Pandemics of the 20th Century
Edwin D. Kilbourne Volume 12, Number 1—January 2006

2005

Rabies Vaccine Baits, Pennsylvania
Virginia M. Dato et al. Volume 11, Number 12—December 2005 Adventitious Viruses and Smallpox Vaccine
Claude Chastel Volume 11, Number 11—November 2005 Evolution of H5N1 Avian Influenza Viruses in Asia
Volume 11, Number 10—October 2005 Streptococcus pneumoniae and Haemophilus influenzae type b Carriage, Central Asia
Stephanie H. Factor et al. Volume 11, Number 9—September 2005 SARS Vaccine Protective in Mice
Konrad Stadler et al. Volume 11, Number 8—August 2005 Adventitious Agents and Smallpox Vaccine in Strategic National Stockpile
Frederick A. Murphy et al. Volume 11, Number 7—July 2005 SARS Vaccine Development
Shibo Jiang et al. Volume 11, Number 7—July 2005 Community-associated Methicillin-resistant Staphylococcus aureus in Pediatric Patients
Theresa J. Ochoa et al. Volume 11, Number 6—June 2005 Emergence and Spread of Streptococcus pneumoniae with erm(B) and mef(A) Resistance
David J. Farrell et al. Volume 11, Number 6—June 2005 Erythromycin-nonsusceptible Streptococcus pneumoniae in Children, 1999–2001
M. Catherine McEllistrem et al. Volume 11, Number 6—June 2005 Persistent Emergence of Dengue
Charles H. Calisher Volume 11, Number 5—May 2005 Vaccine–derived Poliovirus, Thailand, 2003
Piyanit Tharmaphornpilas Volume 11, Number 5—May 2005 Workshop on Carbohydrate Moieties as Vaccine Candidates
Christopher E. Taylor Volume 11, Number 4—April 2005 Emerging Infectious Diseases: a 10-Year Perspective from the National Institute of Allergy and Infectious Diseases
Anthony S. Fauci et al. Volume 11, Number 4—April 2005 Longitudinally Profiling Neutralizing Antibody Response to SARS Coronavirus with Pseudotypes
Nigel J. Temperton et al. Volume 11, Number 3—March 2005 Bat Incidents at Children’s Camps, New York State, 1998–2002
Amy Robbins et al. Volume 11, Number 2—February 2005 Emergent Strain of Human Adenovirus Endemic in Iowa
Gregory C. Gray et al. Volume 11, Number 1—January 2005 HEPA/Vaccine Plan for Indoor Anthrax Remediation
Lawrence M. Wein et al. Volume 11, Number 1—January 2005

2004

Protective Effectiveness of Hantavirus Vaccine
Keeho Park et al. Volume 10, Number 12—December 2004 New Vaccines of Interest to Women
Patricia Fast et al. Volume 10, Number 11—November 2004 New Concepts for Vaccines
Trudy V. Murphy et al. Volume 10, Number 11—November 2004 Evaluating Human Papillomavirus Vaccination Programs
Al V. Taira et al. Volume 10, Number 11—November 2004 Human Papillomavirus and Cervical Cancer
Elizabeth R. Unger et al. Volume 10, Number 11—November 2004 Vaccine Issues for Adult Women
Susan Reef et al. Volume 10, Number 11—November 2004 International Issues in Immunization
Stephen L. Cochi et al. Volume 10, Number 11—November 2004 Potential Public Health Impact of New Tuberculosis Vaccines
Elad Ziv et al. Volume 10, Number 9—September 2004 Predicting Antigenic Variants of Influenza A/H3N2 Viruses
Min-Shi Lee et al. Volume 10, Number 8—August 2004 The Vaccine Book
Bruce G. Weniger Volume 10, Number 7—July 2004 Hepatitis B Infection, Eastern India
Kamalesh Sarkar et al. Volume 10, Number 7—July 2004 Rapid Assessment Tool for Haemophilus influenzae type b Disease in Developing Countries
Daniel R. Feikin et al. Volume 10, Number 7—July 2004 First Report from the Asian Rotavirus Surveillance Network
Joseph S. Bresee et al. Volume 10, Number 6—June 2004 Pediatric Influenza Prevention and Control
Nicola Principi et al. Volume 10, Number 4—April 2004 PorA Variable Regions of Neisseria meningitidis
Joanne E. Russell et al. Volume 10, Number 4—April 2004

2003

Flow Cytometry and T-Cell Response Monitoring after Smallpox Vaccination
Fabrizio Poccia et al. Volume 9, Number 11—November 2003 DNA Vaccine for West Nile Virus Infection in Fish Crows (Corvus ossifragus)
Michael J. Turell et al. Volume 9, Number 9—September 2003 Disease Surveillance and the Academic, Clinical, and Public Health Communities
Robert W. Pinner et al. Volume 9, Number 7—July 2003 Poor Potential Coverage for 7-Valent Pneumococcal Conjugate Vaccine, Malawi
Stephen B. Gordon et al. Volume 9, Number 6—June 2003 Enterovirus 71 Outbreaks, Taiwan: Occurrence and Recognition
Tzou-Yien Lin et al. Volume 9, Number 3—March 2003 Cost Effectiveness of a Potential Vaccine for Human papillomavirus
Gillian D. Sanders et al. Volume 9, Number 1—January 2003

2002

Efficacy of Killed Virus Vaccine, Live Attenuated Chimeric Virus Vaccine, and Passive Immunization for Prevention of West Nile virus Encephalitis in Hamster Model
Robert B. Tesh et al. Volume 8, Number 12—December 2002 Mass Vaccination Campaign Following Community Outbreak of Meningococcal Disease
Gérard Krause et al. Volume 8, Number 12—December 2002 DNA Vaccine Expressing Conserved Influenza Virus Proteins Protective Against H5N1 Challenge Infection in Mice
Suzanne L. Epstein et al. Volume 8, Number 8—August 2002 Passive Antibody Administration (Immediate Immunity) as a Specific Defense Against Biological Weapons
Arturo Casadevall Volume 8, Number 8—August 2002 Smallpox Research Activities: U.S. Interagency Collaboration, 2001
James W. LeDuc et al. Volume 8, Number 7—July 2002 Evaluation in Nonhuman Primates of Vaccines against Ebola Virus
Thomas W. Geisbert et al. Volume 8, Number 5—May 2002 Nasopharyngeal Carriage of Streptococcus pneumoniae in Healthy Children: Implications for the Use of Heptavalent Pnemococcal Conjugate Vaccine
Paola Marchisio et al. Volume 8, Number 5—May 2002 Mapping Lyme Disease Incidence for Diagnostic and Preventive Decisions, Maryland
Christina Frank et al. Volume 8, Number 4—April 2002 Immunization with Heterologous Flaviviruses Protective Against Fatal West Nile Encephalitis
Robert B. Tesh et al. Volume 8, Number 3—March 2002 Eastern Equine Encephalomyelitis Virus Infection in a Horse from California
Robert P. Franklin et al. Volume 8, Number 3—March 2002 Postexposure Treatment and Animal Rabies, Ontario, 1958-2000
Christopher P. Nunan et al. Volume 8, Number 2—February 2002 Absence of Mycoplasma Contamination in the Anthrax Vaccine
Mary Kate Hart et al. Volume 8, Number 1—January 2002

2001

Developing New Smallpox Vaccines
Steven R. Rosenthal et al. Volume 7, Number 6—December 2001 Expanding Global Distribution of Rotavirus Serotype G9: Detection in Libya, Kenya, and Cuba
Nigel A. Cunliffe et al. Volume 7, Number 5—October 2001 Cost-Effectiveness of a Potential Vaccine for Coccidioides immitis
Amber E. Barnato et al. Volume 7, Number 5—October 2001 Fluoroquinolone Resistance among Streptococcus pneumoniae in Hong Kong Linked to the Spanish 23F Clone
Pak Leung Ho et al. Volume 7, Number 5—October 2001

2000

Vaccines for Mucosal Immunity to Combat Emerging Infectious Diseases
Frederik W. van Ginkel et al. Volume 6, Number 2—April 2000

Additional Resources

Centers for Disease Control and Prevention

World Health Organization

The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.